SCHEMBL6460749

SCHEMBL6460749

CC(C)CCCC(Br)CC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.45
LMNA P02545 1/20 0.37
KDM4C Q9H3R0 2/20 0.37
KDM4A O75164 1/20 0.37
PHF8 Q9UPP1 1/20 0.37
KDM2A Q9Y2K7 1/20 0.37
CACNA2D1 P54289 2/20 0.36
CACNB3 P54284 1/20 0.36
CACNA1C Q13936 1/20 0.36
PGR P06401 1/20 0.36
ADRA1A P35348 1/20 0.36
HTR2B P41595 1/20 0.36
CACNA2D2 Q9NY47 1/20 0.36
GPR84 Q9NQS5 4/20 0.35
SLC22A6 Q4U2R8 1/20 0.33
CA1 P00915 1/20 0.33
KDM1A O60341 1/20 0.33
LCK P06239 1/20 0.32
PPARD Q03181 1/20 0.32
ZDHHC20 Q5W0Z9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6465807 0.96 BLM (0.41) BLMLMNAKDM4CKDM4APHF8
SCHEMBL6466029 0.94 KDM4C (0.43) BLMLMNAKDM4CKDM4APHF8
SCHEMBL6465130 0.94 KDM4C (0.43) BLMLMNAKDM4CKDM4APHF8
SCHEMBL6464903 0.94 KDM4C (0.43) BLMLMNAKDM4CKDM4APHF8
SCHEMBL6466529 0.94 KDM4C (0.43) BLMLMNAKDM4CKDM4APHF8
SCHEMBL6462681 0.86 CACNA2D1 (0.39) BLMCACNA2D1CACNB3CACNA1CPGR
SCHEMBL6464981 0.80 GPR84 (0.50) GPR84SLC22A6LCKPPARDZDHHC20
SCHEMBL6463034 0.78 GPR84 (0.59) GPR84SLC22A6LCKPPARDZDHHC20
SCHEMBL4844058 0.77 LMNA (0.46) BLMLMNAGPR84SLC22A6
SCHEMBL10659380 0.77 TSHR (0.41) LMNAGPR84SLC22A6LCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903233-B2 Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-07 US disclosed
US-20030225301-A1 Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester TAKASAGO INTERNATIONAL CORPORATION (JP) 2003-12-04 US disclosed
EP-1344763-A1 Process for producing optically active 3-halogenocarboxylic acid esters and 3-azide-carboxylic acid esters Takasago International Corporation (JP) 2003-09-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225301-A1 Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester HDHD5, APEH, AOC3 BLM 4764/4885LMNA 3776/4885KDM4C 1647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.